Dr. Harpreet Mahal, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1700 St Lukes Blvd, Easton, PA 18045 Phone: 484-526-1000 |
Jarrett Parks, Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3213 Nazareth Rd, Easton, PA 18045 Phone: 484-822-5280 |
Edward J Cumbo, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1800 Sullivan Trl, Suite 200, Easton, PA 18040 Phone: 610-250-8799 Fax: 610-829-1183 |
Okju Patrylo, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2401 Northampton St Ste 130, Easton, PA 18045 Phone: 484-591-7420 Fax: 484-591-7421 |
Rebecca Hannah Markson, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1700 St Lukes Blvd, Easton, PA 18045 Phone: 484-526-1000 |
Dr. Manu Vachhani, M.D. Family Medicine - Adult Medicine Medicare: Accepting Medicare Assignments Practice Location: 3729 Easton Nazareth Hwy, Suite #101, Easton, PA 18045 Phone: 610-253-1994 Fax: 610-253-8184 |
Dr. Jonanthony G Gagliardi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1700 St Lukes Blvd, Easton, PA 18045 Phone: 484-526-1000 |
News Archive
The protein alpha-synuclein is a well-known player in Parkinson's disease and other related neurological conditions, such as dementia with Lewy bodies. Its normal functions, however, have long remained unknown.
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).
News outlets report on issues affecting the doctor workforce, including increased diversity at medical schools and questions about whether rural doctors will qualify for the Medicare payment bonus for primary care physicians.
Ever more people are suffering from cardiac insufficiency, despite significant advances in preventing and minimising damage to the heart.
A Rensselaer researcher has developed a new tool to help unravel the function of an elusive DNA structure. The findings, which were presented today at the 230th national meeting of the American Chemical Society (ACS) in Washington, D.C., could lead to a better understanding of diseases such as cancer and diabetes.
› Verified 2 days ago